HeartWorks Featured on Before the Cure

Dr. Tim Nelson, HeartWorks CEO, featured on the Before the Cure podcast episode cover art

HeartWorks Featured on Before the Cure

What does it take to pursue a cure when the path forward requires building something entirely new?

HeartWorks CEO and Co-founder Dr. Tim Nelson recently joined hosts Timothy Wheeler and David Tsai on Before the Cure, a podcast dedicated to the people, persistence, uncertainty, and ideas behind medical innovation.

In the episode, “Why Did a Doctor Buy a 600,000-Square-Foot Hospital for $1?”, Tim shares the story behind HeartWorks and the decisions that have shaped its approach to congenital heart disease. The conversation explores what it takes to move promising science toward patients, why the traditional pace of innovation isn’t good enough for families waiting for better options, and why HeartWorks continues to build the people, facilities, technology, and infrastructure needed to accelerate progress.

And, of course, they talk about the $1 hospital.

The conversation offers a look at the thinking behind HeartWorks and the belief that changing the future of congenital heart disease will require more than a single discovery. It requires building an entire platform capable of moving discoveries forward.

A huge thank you to Timothy Wheeler, David Tsai, and the entire Before the Cure team for the opportunity to share this story and for creating a platform dedicated to the people working toward breakthroughs long before the outcome is certain.

We hope you’ll take some time to listen to the conversation and learn more about why HeartWorks was built and where we’re headed next.

Listen to the full episode: Why Did a Doctor Buy a 600,000-Square-Foot Hospital for $1? | Dr. Tim Nelson

Share the Post:

Related Posts

The Co-op at HeartWorks: How CHD Patient Data Is Changing Heart Research

Did you know your medical records could help shape the future of CHD treatment? The Co-op at HeartWorks is a free, secure database where CHD patients can upload their records — putting their data directly in the hands of researchers working to develop better therapies. Co-op members are notified when they qualify for new clinical trials, and their data helps identify where gaps in care exist. If you’re living with CHD, joining the Co-op is one of the most powerful things you can do

Read More
HeartWorks lab robot automating patient-specific cell manufacturing for congenital heart disease research

HeartWorks Introduces Lab Robots to Advance Cell Manufacturing

HeartWorks uses six-axis robotic systems to automate portions of patient-specific cell manufacturing, including cell passaging. The robots are designed to perform highly precise, repeatable movements and are part of HeartWorks’ effort to explore how automation and advanced imaging can make personalized cell manufacturing more consistent, efficient, and scalable for congenital heart disease therapies.

Read More

Send A Message

This field is for validation purposes and should be left unchanged.
Name(Required)
Please let us know what's on your mind. Have a question for us? Ask away.